BioDuro and AstraZeneca have expanded their discovery research collaboration for respiratory and inflammation indications. BioDuro will provide research services in the areas of discovery chemistry, discovery biology, ADMET, and DMPK services, in an effort to enhance internal drug discovery and shorten development timelines. “After a successful collaboration involving discovery chemistry, ADMET, and DMPK, AstraZeneca has expanded its collaboration with BioDuro to leverage the strengths of its...